PCA3 and Familial prostate cancer: However, proof of concepts for the meaningful use of lncRNAs present in body fluids has been obtained with the characterization of urinary PCA3 levels as a diagnostic tool in prostate cancer [124], and circulating LIPCAR levels for prognosis after myocardial infarction [125].